miR-184 represses β-catenin and behaves as a skin tumor suppressor

Abstract miR-184-knockout mice display perturbed epidermal stem cell differentiation. However, the potential role of miR-184 in skin pathology is unclear. Here, we report that miR-184 controls epidermal stem cell dynamics and that miR-184 ablation enhances skin carcinogenesis in mice. In agreement,...

Full description

Bibliographic Details
Main Authors: Lubov Turovsky, Ghazal Kheshaiboun, Gharam Yassen, Sara Nagosa, Ilanit Boyango, Aya Amitai-Lange, Swarnabh Bhattacharya, Neta Ilan, Israel Vlodavsky, Daniel Aberdam, Ruby Shalom-Feuerstein, Emily Avitan-Hersh
Format: Article
Language:English
Published: Nature Publishing Group 2024-02-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-024-06554-4
_version_ 1797273042877939712
author Lubov Turovsky
Ghazal Kheshaiboun
Gharam Yassen
Sara Nagosa
Ilanit Boyango
Aya Amitai-Lange
Swarnabh Bhattacharya
Neta Ilan
Israel Vlodavsky
Daniel Aberdam
Ruby Shalom-Feuerstein
Emily Avitan-Hersh
author_facet Lubov Turovsky
Ghazal Kheshaiboun
Gharam Yassen
Sara Nagosa
Ilanit Boyango
Aya Amitai-Lange
Swarnabh Bhattacharya
Neta Ilan
Israel Vlodavsky
Daniel Aberdam
Ruby Shalom-Feuerstein
Emily Avitan-Hersh
author_sort Lubov Turovsky
collection DOAJ
description Abstract miR-184-knockout mice display perturbed epidermal stem cell differentiation. However, the potential role of miR-184 in skin pathology is unclear. Here, we report that miR-184 controls epidermal stem cell dynamics and that miR-184 ablation enhances skin carcinogenesis in mice. In agreement, repression of miR-184 in human squamous cell carcinoma (SCC) enhances neoplastic hallmarks of human SCC cells in vitro and tumor development in vivo. Characterization of miR-184-regulatory network, suggests that miR-184 inhibits pro-oncogenic pathways, cell proliferation, and epithelial to mesenchymal transformation. Of note, depletion of miR-184 enhances the levels of β-catenin under homeostasis and following experimental skin carcinogenesis. Finally, the repression of β-catenin by miR-184, inhibits the neoplastic phenotype of SCC cells. Taken together, miR-184 behaves as an epidermal tumor suppressor, and may provide a potentially useful target for skin SCC therapy.
first_indexed 2024-03-07T14:37:53Z
format Article
id doaj.art-81c6513c80504b699b3cd22ba2134fe7
institution Directory Open Access Journal
issn 2041-4889
language English
last_indexed 2024-03-07T14:37:53Z
publishDate 2024-02-01
publisher Nature Publishing Group
record_format Article
series Cell Death and Disease
spelling doaj.art-81c6513c80504b699b3cd22ba2134fe72024-03-05T20:31:25ZengNature Publishing GroupCell Death and Disease2041-48892024-02-0115211010.1038/s41419-024-06554-4miR-184 represses β-catenin and behaves as a skin tumor suppressorLubov Turovsky0Ghazal Kheshaiboun1Gharam Yassen2Sara Nagosa3Ilanit Boyango4Aya Amitai-Lange5Swarnabh Bhattacharya6Neta Ilan7Israel Vlodavsky8Daniel Aberdam9Ruby Shalom-Feuerstein10Emily Avitan-Hersh11Department of Genetics & Developmental Biology, The Rappaport Faculty of Medicine & Research Institute, Technion Integrated Cancer Center, Technion – Israel Institute of TechnologyDepartment of Genetics & Developmental Biology, The Rappaport Faculty of Medicine & Research Institute, Technion Integrated Cancer Center, Technion – Israel Institute of TechnologyDepartment of Genetics & Developmental Biology, The Rappaport Faculty of Medicine & Research Institute, Technion Integrated Cancer Center, Technion – Israel Institute of TechnologyDepartment of Genetics & Developmental Biology, The Rappaport Faculty of Medicine & Research Institute, Technion Integrated Cancer Center, Technion – Israel Institute of TechnologySkin Cancer Research lab, Clinical research institute (CRIR), Rambam Health Care CampusDepartment of Genetics & Developmental Biology, The Rappaport Faculty of Medicine & Research Institute, Technion Integrated Cancer Center, Technion – Israel Institute of TechnologyDepartment of Genetics & Developmental Biology, The Rappaport Faculty of Medicine & Research Institute, Technion Integrated Cancer Center, Technion – Israel Institute of TechnologyCell Biology and Cancer Science, The Ruth and Bruce Rappaport Faculty of Medicine, Technion Integrated Cancer Center, Technion Israel Institute of TechnologyCell Biology and Cancer Science, The Ruth and Bruce Rappaport Faculty of Medicine, Technion Integrated Cancer Center, Technion Israel Institute of TechnologyUniversité de Paris Cité, INSERM U1138, Centre des CordeliersDepartment of Genetics & Developmental Biology, The Rappaport Faculty of Medicine & Research Institute, Technion Integrated Cancer Center, Technion – Israel Institute of TechnologySkin Cancer Research lab, Clinical research institute (CRIR), Rambam Health Care CampusAbstract miR-184-knockout mice display perturbed epidermal stem cell differentiation. However, the potential role of miR-184 in skin pathology is unclear. Here, we report that miR-184 controls epidermal stem cell dynamics and that miR-184 ablation enhances skin carcinogenesis in mice. In agreement, repression of miR-184 in human squamous cell carcinoma (SCC) enhances neoplastic hallmarks of human SCC cells in vitro and tumor development in vivo. Characterization of miR-184-regulatory network, suggests that miR-184 inhibits pro-oncogenic pathways, cell proliferation, and epithelial to mesenchymal transformation. Of note, depletion of miR-184 enhances the levels of β-catenin under homeostasis and following experimental skin carcinogenesis. Finally, the repression of β-catenin by miR-184, inhibits the neoplastic phenotype of SCC cells. Taken together, miR-184 behaves as an epidermal tumor suppressor, and may provide a potentially useful target for skin SCC therapy.https://doi.org/10.1038/s41419-024-06554-4
spellingShingle Lubov Turovsky
Ghazal Kheshaiboun
Gharam Yassen
Sara Nagosa
Ilanit Boyango
Aya Amitai-Lange
Swarnabh Bhattacharya
Neta Ilan
Israel Vlodavsky
Daniel Aberdam
Ruby Shalom-Feuerstein
Emily Avitan-Hersh
miR-184 represses β-catenin and behaves as a skin tumor suppressor
Cell Death and Disease
title miR-184 represses β-catenin and behaves as a skin tumor suppressor
title_full miR-184 represses β-catenin and behaves as a skin tumor suppressor
title_fullStr miR-184 represses β-catenin and behaves as a skin tumor suppressor
title_full_unstemmed miR-184 represses β-catenin and behaves as a skin tumor suppressor
title_short miR-184 represses β-catenin and behaves as a skin tumor suppressor
title_sort mir 184 represses β catenin and behaves as a skin tumor suppressor
url https://doi.org/10.1038/s41419-024-06554-4
work_keys_str_mv AT lubovturovsky mir184repressesbcateninandbehavesasaskintumorsuppressor
AT ghazalkheshaiboun mir184repressesbcateninandbehavesasaskintumorsuppressor
AT gharamyassen mir184repressesbcateninandbehavesasaskintumorsuppressor
AT saranagosa mir184repressesbcateninandbehavesasaskintumorsuppressor
AT ilanitboyango mir184repressesbcateninandbehavesasaskintumorsuppressor
AT ayaamitailange mir184repressesbcateninandbehavesasaskintumorsuppressor
AT swarnabhbhattacharya mir184repressesbcateninandbehavesasaskintumorsuppressor
AT netailan mir184repressesbcateninandbehavesasaskintumorsuppressor
AT israelvlodavsky mir184repressesbcateninandbehavesasaskintumorsuppressor
AT danielaberdam mir184repressesbcateninandbehavesasaskintumorsuppressor
AT rubyshalomfeuerstein mir184repressesbcateninandbehavesasaskintumorsuppressor
AT emilyavitanhersh mir184repressesbcateninandbehavesasaskintumorsuppressor